Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society

Circ J. 2011;75(2):474-503. doi: 10.1253/circj.cj-88-0007. Epub 2011 Jan 20.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Cardiovascular Agents / therapeutic use
  • Female
  • Giant Cell Arteritis / diagnosis
  • Giant Cell Arteritis / etiology
  • Giant Cell Arteritis / pathology
  • Giant Cell Arteritis / therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Polyarteritis Nodosa / diagnosis
  • Polyarteritis Nodosa / etiology
  • Polyarteritis Nodosa / pathology
  • Polyarteritis Nodosa / therapy
  • Syndrome
  • Systemic Vasculitis / diagnosis
  • Systemic Vasculitis / etiology
  • Systemic Vasculitis / pathology
  • Systemic Vasculitis / therapy
  • Takayasu Arteritis / diagnosis
  • Takayasu Arteritis / etiology
  • Takayasu Arteritis / pathology
  • Takayasu Arteritis / therapy
  • Thromboangiitis Obliterans / diagnosis
  • Thromboangiitis Obliterans / etiology
  • Thromboangiitis Obliterans / pathology
  • Thromboangiitis Obliterans / therapy
  • Vasculitis / classification
  • Vasculitis / diagnosis
  • Vasculitis / etiology
  • Vasculitis / pathology
  • Vasculitis / therapy*

Substances

  • Cardiovascular Agents
  • Immunosuppressive Agents